Your browser doesn't support javascript.
loading
Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.
Contreras, Cristina F; Higham, Christine S; Behnert, Astrid; Kim, Kailyn; Stieglitz, Elliot; Tasian, Sarah K.
Afiliação
  • Contreras CF; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, Philadelphia, Pennsylvania.
  • Higham CS; San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, Division of Pediatric Bone Marrow Transplantation, University of California, San Francisco, California.
  • Behnert A; San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, Division of Hematology-Oncology, University of California, San Francisco, California.
  • Kim K; Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Stieglitz E; San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, Division of Hematology-Oncology, University of California, San Francisco, California.
  • Tasian SK; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, Philadelphia, Pennsylvania.
Pediatr Blood Cancer ; 68(1): e28718, 2021 01.
Article em En | MEDLINE | ID: mdl-33098744

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article